ProofPilot welcomes the addition of Michelle Everill, VP, Global Trial Optimization at Alnylam Pharmaceuticals, and CEO of Michelle Everill Coaching LLC, to its Strategic Advisory Board.

ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series C financing, led by Sopris Capital with Mitsui & Co. (U.S.A.), Inc. participating.

ProofPilot is thrilled to share that it has been named as a finalist in two prestigious categories at the 2024 Citeline Awards in partnership with Moderna.